Early Access Care is thrilled to support #ASCO25!

Early Access Care is thrilled to support #ASCO25!

Get the latest updates from Early Access Care at the 2025 ASCO Annual Meeting, showcasing innovations in oncology access and investigational medicine pathways.
ASCO2025 EAC

The EAC team will be attending ASCO '25. Join us to explore how we’re transforming Expanded Access for oncology programs worldwide. As a full-service specialty provider of Expanded Access, Compassionate Use and Post-Trial Access, EAC delivers customized, end-to-end solutions for bio/pharma companies—whether for global single-patient or intermediate-size protocols. Our team has extensive experience with global oncology programs, from early development to product country launch. Our team will leverage our regulatory and operational expertise for your program.

💡 From strategic consultation to seamless global operational execution, our experienced team is here to help you design and deliver programs that prioritize both patients and performance. With compassion at the core of everything we do, we’re on a mission to accelerate access to investigational therapies for those who need them most.